Compare Mark Dynamics Indonesia Tbk. (MARK) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mark Dynamics Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mark Dynamics Indonesia Tbk. trades at Rp1,105 (market cap 4.2T, 13.29M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mark Dynamics Indonesia Tbk. is far larger — about 40.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MARK | SCPI | |
|---|---|---|
Market Cap | 4.2T | 104.4B |
Volume | 13.29M | — |
Lot | 132.92K | — |
Turnover | 14.42B | — |
Average Price | 1,084.73 | — |
Value | 14.42B | — |
Indicative Equilibrium Price | 1,105 | — |
Indicative Equilibrium Volume | 83 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mark Dynamics Indonesia Tbk.
PT Mark Dynamics Indonesia Tbk (the Company) was established based on the Deed No. 03 dated April 10, 2002 drawn up before Fibriani Magdalena Hasibuan, SH Notary in Medan. The Company started its commercial operations in September 2003. In 2013 the company decided to invest by purchasing 100% of Honor Tower SDN BHD.
Read more on MARK →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
